Dr. Guerrero brings to DIA experience as a CEO, Director, Project Manager, and Quality Assurance Auditor for the pharmaceutical/CRO/SMO industry developing and managing clinical trials from phase I-IV on drugs, biologics and medical devices. He is President/CEO of Accelerium Clinical Research in Monterrey, Mexico, a clinical research consortium where he provides scientific, medical, and business leadership for the evaluation of potential drugs, biologics, and medical devices development and clinical research activities in Mexico and Latin America. He is responsible for establishing and implementing clinical trial activities based on specific regulatory strategies, and for teams tasked with managing the budgets and timelines for these activities. He previously served as Director of the Hospital OCA/Monterrey International Clinical Research Center where he managed a multi specialty hospital investigator network to conduct clinical trials for the International pharmaceutical and CRO industry, and he has also served as a Director of Latin American for INC Research, CRO based in Raleigh, North Carolina, and Director of the Mexican Institute for Clinical Research (IMIC) in Mexico City. He has experience in the clinical research arena developing and implementing processes and procedures to train and manage clinical teams and monitor clinical trials in accordance with the ICH/GCP guidelines and local regulations. He has coordinated numerous educational events related to ICH GCP guidelines among the medical and regulatory communities in Mexico and Latin America. He received his Medical Degree from the School of Medicine in Juarez, Mexico. Afterwards, his medical research in the emerging tissue allograft transplant industry led to an opportunity for him to coordinate and manage operations for a transplant laboratory. He subsequently built and managed other organizations in the US tissue banking industry, including developing and implementing their operational policies.